- Home
- CELC vs VBNK Comparison
CELC vs VBNK Comparison
Compare CELC & VBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- VBNK
- Stock Information
- Founded
- CELC 2011
- VBNK 1980
- Country
- CELC United States
- VBNK Canada
- Employees
- CELC N/A
- VBNK N/A
- Industry
- CELC Medical Specialities
- VBNK Commercial Banks
- Sector
- CELC Health Care
- VBNK Finance
- Exchange
- CELC Nasdaq
- VBNK Nasdaq
- Market Cap
- CELC 440.7M
- VBNK 441.5M
- IPO Year
- CELC 2017
- VBNK 2021
- Fundamental
- Price
- CELC $13.15
- VBNK $12.69
- Analyst Decision
- CELC Strong Buy
- VBNK Strong Buy
- Analyst Count
- CELC 6
- VBNK 3
- Target Price
- CELC $30.17
- VBNK $19.00
- AVG Volume (30 Days)
- CELC 184.2K
- VBNK 87.6K
- Earning Date
- CELC 03-26-2025
- VBNK 03-05-2025
- Dividend Yield
- CELC N/A
- VBNK 0.57%
- EPS Growth
- CELC N/A
- VBNK N/A
- EPS
- CELC N/A
- VBNK 1.07
- Revenue
- CELC N/A
- VBNK $80,302,117.00
- Revenue This Year
- CELC N/A
- VBNK N/A
- Revenue Next Year
- CELC N/A
- VBNK $40.97
- P/E Ratio
- CELC N/A
- VBNK $14.89
- Revenue Growth
- CELC N/A
- VBNK 3.59
- 52 Week Low
- CELC $10.35
- VBNK $9.48
- 52 Week High
- CELC $22.19
- VBNK $18.38
- Technical
- Relative Strength Index (RSI)
- CELC 60.85
- VBNK 31.84
- Support Level
- CELC $12.55
- VBNK $13.36
- Resistance Level
- CELC $13.25
- VBNK $13.86
- Average True Range (ATR)
- CELC 0.68
- VBNK 0.44
- MACD
- CELC 0.14
- VBNK -0.07
- Stochastic Oscillator
- CELC 85.79
- VBNK 2.21
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About VBNK VersaBank
VersaBank is a Canadian Schedule I chartered bank with a difference. It has 3 operating segments: Digital Banking Canada, Digital Banking USA and DRTC. It's, cloud-based, business-to-business deposit and lending model provides valued-added solutions to Canadian financial intermediary partners, enabling them to focus on growing their own businesses faster and more profitably. It obtains all of its deposits and provides the majority of its loans and leases electronically, with deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, Company established a wholly owned, subsidiary. Geographically located in Canada and USA.